Your browser doesn't support javascript.
loading
[The effect of palonosetron on rocuronium-induced withdrawal movement]. / O efeito de palonosetron sobre o movimento de retração induzido por rocurônio.
Park, Ki-Bum; Jeon, Younghoon; Yi, Junggu; Kim, Ji-Hyun; Chung, Seung-Yeon; Kwak, Kyung-Hwa.
Afiliação
  • Park KB; Keimyoung University, School of Medicine, Department of Anesthesiology and Pain Medicine, Daegu, República da Coreia.
  • Jeon Y; Kyungpook National University, School of Dentistry, Department of Anesthesiology, Daegu, República da Coreia.
  • Yi J; Kyungpook National University, School of Medicine, Department of Anesthesiology and Pain Medicine, Daegu, República da Coreia.
  • Kim JH; Kyungpook National University, School of Medicine, Department of Anesthesiology and Pain Medicine, Daegu, República da Coreia.
  • Chung SY; Kyungpook National University, School of Medicine, Department of Anesthesiology and Pain Medicine, Daegu, República da Coreia.
  • Kwak KH; Kyungpook National University, School of Medicine, Department of Anesthesiology and Pain Medicine, Daegu, República da Coreia. Electronic address: kwakkh@knu.ac.kr.
Rev Bras Anestesiol ; 67(4): 337-341, 2017.
Article em Pt | MEDLINE | ID: mdl-28040235
BACKGROUND: Rocuronium causes pain and withdrawal movement during induction of anesthesia. In this study, palonosetron was investigated to have analgesic effect on the reduction of rocuronium-induced withdrawal movement. METHODS: 120 patients were randomly assigned to one of three groups to receive either saline, lidocaine 20mg, or palonosetron 0.075mg with a tourniquet applied two minutes before thiopental sodium (5mg.kg-1) was given intravenously. After loss of consciousness, rocuronium (0.6mg.kg-1) was injected and the withdrawal movement was estimated by 4-point scale in a double-blind manner. RESULTS: The overall incidence of rocuronium withdrawal movement was 50% with lidocaine (p=0.038), 38% with palonosetron (p=0.006) compared with 75% for saline. The incidence of no pain to mild pain was significantly lower in the lidocaine and palonosetron groups (85% and 92% respectively) than in the saline group (58%). However, there was no significant difference in withdrawal movement between the lidocaine and palonosetron groups. There was no severe movement with palonosetron. CONCLUSION: Pretreatment of palonosetron with venous occlusion may attenuate rocuronium-induced withdrawal movement as effective as the use of lidocaine. It suggested that peripheral action of palonosetron was effective to reduce rocuronium-induced withdrawal movement.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Neuromusculares não Despolarizantes / Antagonistas do Receptor 5-HT3 de Serotonina / Rocurônio / Palonossetrom / Movimento Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged Idioma: Pt Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Neuromusculares não Despolarizantes / Antagonistas do Receptor 5-HT3 de Serotonina / Rocurônio / Palonossetrom / Movimento Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged Idioma: Pt Ano de publicação: 2017 Tipo de documento: Article